Candel Therapeutics, Inc. (CADL) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$4.79
Day's range
$5.17

Candel Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 02/17/2026 8.23 M $46.52 M   0.01% 15.00%
BLACKROCK, INC. 02/12/2026 2.86 M $16.17 M   20.27% 5.21%
ACORN CAPITAL ADVISORS, LLC 02/17/2026 2.58 M $14.58 M   0.00% 4.70%
VANGUARD GROUP INC 01/29/2026 2.31 M $13.02 M   14.84% 4.20%
PORTOLAN CAPITAL MANAGEMENT, LLC 02/17/2026 1.70 M $9.58 M   22.49% 3.09%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 977.51 K $5.52 M   5.31% 1.78%
STATE STREET CORP 02/13/2026 792.22 K $4.48 M   15.02% 1.44%
HALTER FERGUSON FINANCIAL INC. 02/05/2026 748.06 K $4.23 M   7.17% 1.36%
SANDS CAPITAL VENTURES, LLC 02/13/2026 405.84 K $2.29 M   0.00% 0.74%
NORTHERN TRUST CORP 02/17/2026 295.44 K $1.67 M   -3.70% 0.54%
CITADEL ADVISORS LLC 02/17/2026 226.36 K $1.28 M   -10.28% 0.41%
TANAGER WEALTH MANAGEMENT LLP 01/26/2026 198.18 K $1.12 M   0.00% 0.36%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 137.41 K $776.36 K   -38.61% 0.25%
MORGAN STANLEY 02/13/2026 134.03 K $757.28 K   76.49% 0.24%
JANE STREET GROUP, LLC 02/12/2026 132.40 K $748.06 K   19.93% 0.24%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 121.00 K $683.67 K   0.00% 0.22%
CITADEL ADVISORS LLC 02/17/2026 110.00 K $621.50 K   -11.22% 0.20%
UBS GROUP AG 01/29/2026 104.34 K $589.52 K   10.92% 0.19%
TWO SIGMA INVESTMENTS, LP 02/17/2026 99.20 K $560.48 K   -27.12% 0.18%
BANK OF NEW YORK MELLON CORP 02/10/2026 95.21 K $537.92 K   0.68% 0.17%
NUVEEN, LLC 02/12/2026 92.48 K $522.52 K   -55.89% 0.17%
COMMONWEALTH EQUITY SERVICES, LLC 02/12/2026 82.35 K $465.25 K   0.15% 0.15%
COLONY GROUP, LLC 02/13/2026 81.82 K $462.26 K   100.00% 0.15%
WELLS FARGO & COMPANY/MN 02/13/2026 73.90 K $417.53 K   180.87% 0.13%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 73.00 K $412.45 K   -22.09% 0.13%
BARCLAYS PLC 02/13/2026 69.34 K $391.79 K   16.36% 0.13%
ALLIANCEBERNSTEIN L.P. 02/17/2026 69.11 K $390.47 K   0.00% 0.13%
02/17/2026 66.75 K $377.14 K   100.00% 0.12%
GOLDMAN SACHS GROUP INC 03/25/2026 65.09 K $367.73 K   80.69% 0.12%
LIDO ADVISORS, LLC 02/10/2026 60.20 K $307.03 K   0.00% 0.11%
BIRCHVIEW CAPITAL, LP 02/13/2026 60.00 K $339.00 K   0.00% 0.11%
HB WEALTH MANAGEMENT, LLC 01/28/2026 58.35 K $329.65 K   0.00% 0.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 02/17/2026 55.10 K $311.32 K   0.00% 0.10%
STATE OF WISCONSIN INVESTMENT BOARD 02/17/2026 52.15 K $294.63 K   -3.52% 0.10%
BANK OF AMERICA CORP /DE/ 02/17/2026 51.28 K $289.74 K   7.64% 0.09%
RHUMBLINE ADVISERS 02/13/2026 51.01 K $288.17 K   -4.91% 0.09%
ALPS ADVISORS INC 02/12/2026 45.08 K $254.70 K   71.55% 0.08%
MONETA GROUP INVESTMENT ADVISORS LLC 02/12/2026 42.52 K $240.22 K   4.94% 0.08%
MARTINGALE ASSET MANAGEMENT L P 02/13/2026 37.52 K $211.98 K   100.00% 0.07%
RAYMOND JAMES FINANCIAL INC 02/18/2026 33.00 K $186.45 K   48.89% 0.06%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 30.50 K $172.33 K   -61.29% 0.06%
LPL FINANCIAL LLC 02/11/2026 28.65 K $161.89 K   33.87% 0.05%
DEUTSCHE BANK AG\ 02/11/2026 28.38 K $160.32 K   6.44% 0.05%
JANNEY MONTGOMERY SCOTT LLC 02/11/2026 27.07 K $153.00 K   -10.91% 0.05%
VIRTU FINANCIAL LLC 02/23/2026 26.83 K $152.00 K   100.00% 0.05%
PRICE T ROWE ASSOCIATES INC /MD/ 02/17/2026 25.81 K $146.00 K   31.45% 0.05%
KRILOGY FINANCIAL LLC 01/27/2026 24.00 K $144.24 K   100.00% 0.04%
XTX TOPCO LTD 02/17/2026 23.78 K $134.33 K   100.00% 0.04%
STRATOS WEALTH ADVISORS, LLC 01/20/2026 23.00 K $129.95 K   0.00% 0.04%
JPMORGAN CHASE & CO 02/11/2026 21.63 K $122.19 K   21.26% 0.04%

Candel Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 112 institutional investors and hedge funds held shares of Candel Therapeutics Inc. The most heavily invested institutionals were:

Halter Ferguson Financial Inc.: 904,051

Sands Capital Ventures, LLC: 405,837

VANGUARD FIDUCIARY TRUST CO: 280,451

Tanager Wealth Management LLP: 198,175

UBS Group AG: 149,855

Bank of New York Mellon Corp: 136,266

43.05% of Candel Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 27.21 M shares in the last 24 months. This purchase volume represents approximately $139.61 M in transactions.